Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Exec Compensation
confidence 95%
filed 2026-07-22
Item 5.02
The disclosure centers on the Compensation Committee's recommendation and Board adoption of a 2026 Performance Stock Unit Program for senior executive officers, including the establishment of PSU awards with specific vesting conditions, settlement terms, and change-of-control provisions. This is a compensatory arrangement for named executives under Item 5.02(e), distinct from an appointment or departure. The materiality is clear given the program's scope, the market-vesting conditions tied to stock price thresholds, and the three-year settlement timeline affecting executive incentive compensation.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 92%
filed 2026-07-22
The disclosure reports issuance of 2.5 million Class A and 200,000 Class B ordinary shares to More Healthy Holdings Limited (the holding vehicle of Mr. Weiguang Yang, the CEO and Chairman) on July 21, 2026, "in consideration and acknowledgement of Mr. Weiguang Yang's services rendered to the Company." This is an equity grant to a named executive officer approved by the Audit Committee and Compensation Committee, fitting the definition of executive compensation. The transaction is material because it results in Mr. Yang holding 99.45% of aggregate voting power and represents a substantial equity award to the controlling executive.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 92%
filed 2026-07-22
EX-99.1
The disclosure announces approval by the Nomination, Governance and Compensation Committee of a grant of 15,933 stock options to eligible employees under the Dr. Reddy's Employees Stock Option Scheme, 2018, with an exercise price of Rs. 1,206 per share and 100% vesting over 3 years. This is a compensatory arrangement for employees and falls squarely within exec_compensation. The filing is made under SEBI Regulation 30 and includes detailed terms required by the SEBI Master Circular, indicating material disclosure of equity-based compensation.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-21
Item 5.02
The disclosure centers on Board approval of a one-time discretionary cash award of $100,000 to Marcus Laun, the President and interim CEO/CFO, in recognition of his service and leadership. This is a compensatory arrangement for a named executive officer approved outside the regular incentive program, fitting the definition of exec_compensation under Item 5.02(e). The award is material as it represents a significant discretionary payment to a senior executive.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-07-21
Item 5.02
First Amendment to the Executive Employment Agreement for President and CEO Tamria Zertuche extends her employment term through July 31, 2029 and establishes a new annual base salary of $935,000 effective August 1, 2026, along with eligibility for incentive plans and severance benefits.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 85%
filed 2026-07-21
The Board approved an increase in ordinary shares reserved for issuance under the Company's Amended and Restated 2019 Equity Incentive Plan by 3,834,244 shares (from 11,875,977 to 15,710,221). This is a material amendment to the equity compensation plan that expands the pool available for executive and employee equity grants, directly affecting the compensatory arrangements available to named executives and other employees.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 88%
filed 2026-07-21
Item 5.02
Mitesco issued Series X Preferred Stock and restricted common stock as compensatory arrangements to executives and directors: 4,800 shares ($120,000) to the CEO, 2,400 shares ($60,000) to each of two directors, and 2,400 shares ($60,000) to an acquisition advisor. The issuances materially affect the company's capital structure and governance, with preferred shareholders obtaining over 59% voting control and a cumulative 10% dividend obligation.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-21
Item 5.02
Shareholders approved the Radnostix Inc. 2026 Incentive Plan, a new equity incentive plan authorizing 12,000,000 shares for awards to employees, officers, directors, and service providers. The plan replaces the prior equity plan and establishes material terms for executive and director compensation eligibility.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-21
Item 5.02
The company entered into Executive Employment Agreements effective July 17, 2026, with CEO Ricardo Enrique Silva Canelon and COO Andrew Gaudet, establishing equity-based compensation arrangements whereby Canelon receives 36 million restricted shares and Gaudet receives 12 million restricted shares, both fully vested upon board approval and execution.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-07-21
The filing discloses two compensatory arrangements for officers and employees under Item 5.02: (1) a board determination regarding acceleration of approximately 1.6 million PSU awards in connection with the Merger Transactions closing on July 13, 2026, and (2) a grant of 360,000 restricted stock awards to officers and employees on July 15, 2026 under the 2023 Amended and Restated Omnibus Incentive Plan. Both are equity compensation arrangements materially affecting executive and employee incentive structures.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-07-20
Item 5.02
The filing discloses adoption of the 2026 Short-Term Incentive Plan establishing annual cash incentive compensation for named executive officers with specific performance goals and payout schedules, and an amended employment agreement reducing CEO Todd Brickhouse's base salary to $1,750,000 effective July 25, 2026. These are compensatory arrangements for officers that would materially affect investor assessment of executive compensation structure and CEO pay.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-20
Item 5.02
The company granted RSUs and PSUs to CEO Asim Akram and CFO Robert Nadolny, and amended their RSU Award Agreements and employment agreements to modify change-of-control vesting provisions and establish new equity award treatment in M&A scenarios.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 75%
filed 2026-07-20
EX-99.1
Founder and CEO Dr. Silviu Itescu exercised 1,885,334 options at A$1.45 per share, investing A$2,733,734 to increase his shareholding to 80,844,262 shares, reflecting the exercise of compensatory equity arrangements.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-20
Item 5.02
The Board adopted a new Short-Term Incentive Cash Compensation Plan and amended and restated the Long-Term Cash Incentive Plan, both effective July 14, 2026, governing annual cash incentive awards and long-term compensation for named executive officers. The Long-Term Plan amendment materially expands vesting rights by allowing all unvested awards to vest upon retirement at age 65 with three years of service, regardless of grant date—a significant change from the prior requirement that awards be granted at least three years before retirement. These are compensatory arrangements for officers subject to Section 16 disclosure under Item 5.02(e).
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 92%
filed 2026-07-17
Sony announced the disposal of 1,142,196 treasury shares upon vesting of restricted stock units (RSUs) granted to directors, officers, and employees under its stock compensation plan. The announcement details the vesting mechanics, allottees (including 1 director and 1 corporate executive officer of the Corporation), and the total disposal price of approximately 3.9 billion yen. This is a material disclosure of compensatory arrangements involving equity grants and their settlement, falling squarely within exec_compensation rather than a routine administrative matter.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 95%
filed 2026-07-17
EX-99.1
This announcement discloses the grant of 16,220,972 restricted share units (RSUs) to 438 employees under the 2026 Share Incentive Plan on July 17, 2026, representing approximately 0.36% of total issued shares. The disclosure details vesting schedules, performance conditions, clawback mechanisms, and the rationale for the grants—all hallmarks of executive and employee compensation arrangements. While the grantees are not named executives, the scale and structure of this equity grant constitute a material compensatory arrangement requiring disclosure under Hong Kong Listing Rules 17.06A–C.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 92%
filed 2026-07-17
EX-99.1
This exhibit is the 2026 Omnibus Share Incentive Plan adopted by the Board on July 13, 2026. It establishes a comprehensive equity compensation framework authorizing grants of options, restricted shares, share units, and cash-based awards to employees, consultants, and directors. The plan document itself—setting forth the terms, conditions, and administration of compensatory arrangements—constitutes a material disclosure of executive and employee compensation arrangements under Item 5.02(e) equivalent disclosure obligations for foreign private issuers.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-17
Item 5.02
The Board approved a comprehensive executive compensation program for fiscal 2027 covering four named executive officers (Covered NEOs), including detailed annual incentive targets (50–150% of base salary based on operating income and revenue metrics) and long-term incentive awards (65% RSUs, 35% PSUs with three-year performance periods). This is a material compensatory arrangement disclosure under Item 5.02(e), distinct from any executive departure or appointment.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 92%
filed 2026-07-17
The disclosure announces the formal implementation of previously approved share option arrangements for directors and the CEO. Specifically, it grants 400,000 options to Non-Executive Director Mark Thorpe (at £2.55 exercise price), 100,000 options to Non-Executive Director Michael Schlumpberger (at £1.31), and grants a new EMI option of 181,817 shares to CEO Oliver Friesen (at 10.75p) while extending his original option by five years and providing tax indemnification. These are compensatory arrangements for named executives that would materially affect investor assessment of executive remuneration and equity dilution.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-16
Item 5.02
The disclosure centers on compensatory arrangements granted to two named executives: stock options to purchase 2,700,000 shares for CEO Gerald Bartholomew Smith and 1,100,000 shares for COO Laine Mihalchick Moljo under the 2026 Omnibus Incentive Plan, with detailed vesting terms and change-of-control provisions. This is a classic equity grant arrangement under Item 5.02(e), distinct from an appointment or departure.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-07-16
Item 5.02
The Board approved one-time lump sum cash bonuses for CEO Lindsay Androski and CFO Tuan Nguyen tied to litigation settlement proceeds, with Androski receiving 1.5% of noncontingent payments ($178M), 2.0% of contingent proceeds, and 2.5% of Pfizer/BioNTech litigation proceeds, and Nguyen receiving 0.25% of noncontingent proceeds and potential future bonuses.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-07-16
Item 5.02
Shareholders approved an amendment to the 2018 Equity Incentive Plan increasing the share pool by 2,500,000 ordinary shares, expanding the equity available for compensatory grants to officers and directors.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-16
Item 5.02
QumulusAI, Inc. shareholders approved and adopted the 2026 Equity Incentive Plan, which permits grants of stock options, restricted stock units, performance awards, and other equity-based compensation to employees, directors, and consultants, with an initial share pool of 4,770,000 shares and annual increases.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-16
Item 5.02
The disclosure centers on a performance-based restricted stock unit (PSU) award granted to CEO Sridhar Ramaswamy on July 15, 2026, consisting of 1,000,000 shares with stock price milestones designed to create up to $100 billion in stockholder value. This is a compensatory arrangement for a named executive officer disclosed under Item 5.02(e), distinct from an appointment or departure. The award's material terms—including vesting conditions, performance periods, and clawback provisions—are detailed, making this a significant executive compensation disclosure material to investors assessing executive incentive alignment and retention strategies.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-16
Item 5.02
The disclosure centers on an updated offer letter for David Vetter as Chief Legal Officer, detailing compensatory arrangements including a $670,000 annual base salary, 100% bonus target, and $1.5 million in equity awards (60% time-based, 40% performance-based). While the filing is under Item 5.02(e), the principal disclosed action is the modification of executive compensation terms, not a departure or appointment, making exec_compensation the most salient classification.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 75%
filed 2026-07-16
Item 8.01
Ryan Steelberg, the President, CEO, and Chairman, voluntarily reduced his salary by 50% from $665,000 to $332,500 effective July 14, 2026. This is a material modification to executive compensation arrangements disclosed under Item 8.01. While the reduction is voluntary and supportive of cost initiatives, it represents a significant change to a named executive's compensation that would affect investor assessment of the company's financial condition and leadership commitment.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 75%
filed 2026-07-16
Item 5.02
The disclosure centers on an amendment to a Director Services Agreement with William P. Foley II that modifies his compensatory arrangement by deleting a provision permitting him to sell 50% of his shares back to Cannae at defined prices. This is a material modification to an executive's equity-related compensation arrangement, triggered by the closing of the Brasada Ranch sale. While the transaction itself is M&A-related, the Item 5.02 disclosure focuses on the compensatory arrangement amendment rather than the sale itself.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 92%
filed 2026-07-15
EX-99.1
This exhibit is the "Second Amended and Restated 2019 Share Incentive Plan" for NetEase, Inc., which establishes the framework for granting Restricted Share Units and Options to Eligible Participants (Employees, Directors, and Consultants). The document sets forth the purposes, definitions, and governance structure for equity compensation awards. As a material amendment to the company's equity incentive plan affecting director and officer compensation arrangements, this constitutes an executive compensation disclosure under the taxonomy.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-07-15
Item 5.02
TriCo Bancshares approved a special one-time transaction bonus of $2,500,000 to Richard P. Smith, TriCo's Chairman, President and CEO, contingent on continued employment through merger closing.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 95%
filed 2026-07-15
EX-99.1
This announcement discloses the grant of 1,255,122 restricted share units (RSUs) to 47 employees on July 15, 2026, pursuant to the 2025 Share Incentive Scheme. The disclosure details the vesting schedules, terms, and conditions of the equity awards. Although the grantees are employees rather than named executives, this is a material compensatory arrangement involving equity grants that would affect investor assessment of the company's capital structure and employee incentive practices. The RSUs represent approximately 0.07% of issued shares and are subject to service-based vesting conditions over multiple years.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 75%
filed 2026-07-15
Item 5.02
The disclosure centers on compensatory arrangements for a departing officer: a severance agreement providing $365,775.12 in severance, COBRA premium coverage, conditional change-in-control benefits (18 months base salary plus 2026 bonus target), and a consulting agreement at $1,000/hour. While Valerie Barnett's departure as Chief Legal Officer occurred on June 29, 2026, the material 8-K event filed on July 15 focuses on the severance and consulting compensation arrangements negotiated on July 9, 2026, making this primarily an exec_compensation disclosure under Item 5.02(e).
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 92%
filed 2026-07-15
The 6-K discloses a grant of 14,060 warrants to employees on July 14, 2026, with an exercise price of $265.57 per share and a four-year vesting schedule (25% at one year, then 1/36th monthly). This is a compensatory arrangement for named executives and employees under the company's Articles of Association, materially affecting equity incentive arrangements and shareholder dilution.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 92%
filed 2026-07-15
EX-99.1
This exhibit is an Amended and Restated 2012 Share Option Plan for PolyPid Ltd., which establishes the terms, administration, and mechanics of equity compensation for employees, officers, directors, and service providers. The document sets forth vesting schedules, exercise prices, and other material terms of option grants. As a plan amendment affecting compensatory arrangements for multiple classes of participants, this constitutes a disclosure of executive and employee compensation arrangements that would be material to a reasonable investor's assessment of the company's capital structure and incentive practices.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-15
The filing discloses compensatory arrangements for three named executives: (1) a discretionary equity award of 50,000 RSUs to the Chief Operating Officer (Amaree Vichairattanawong), fully vested on grant date July 10, 2026; and (2) option awards to CEO Justin Kenna (1,045,712 shares) and CFO Michael Munoz (301,249 shares), both granted July 10, 2026 with 62.5% vesting immediately and 37.5% vesting one year later. The Item 5.02(e) disclosure centers on these equity grants and compensatory arrangements rather than any departure or appointment.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 85%
filed 2026-07-15
Item 5.02
The disclosure centers on the Compensation Committee's amendment to the 2026 Inducement Stock Plan, reducing authorized shares from 2,000,000 to 1,538,000. This is a compensatory arrangement amendment affecting equity grants available for new and returning employees, which falls squarely within exec_compensation under Item 5.02(e). While the amendment reduces rather than expands the pool, it materially affects the compensation framework and equity incentive structure available to officers and employees.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-07-14
Item 5.02
Van A. Dukeman's employment term as CEO was extended through July 1, 2029, with a material compensatory arrangement consisting of a one-time retention award of restricted stock units valued at $2,067,749.88 vesting on July 1, 2029, plus enhanced severance and benefit protections upon qualifying termination.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-07-14
Item 5.02
The filing discloses a change in control agreement entered into with Bradley M. Kool, Executive Vice President and Chief Financial Officer, on July 8, 2026. The agreement specifies severance arrangements (three times base salary plus bonus, COBRA reimbursement for 18 months) and renewal terms tied to board performance evaluations. This is a compensatory arrangement for a named executive officer that would materially affect investor assessment of the company's financial obligations and executive incentives.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-14
Item 5.02
The filing discloses compensatory arrangements for two named executives: Christopher V. Vitale (CEO) received a $178,000 cash bonus and 8,700 restricted shares vesting over three years, while Adrienne M. Uleau (CFO) received a $64,000 cash bonus and 2,250 restricted shares on the same schedule. Additionally, the Company approved salary increases for both executives effective July 27, 2026 ($395,000 for Vitale and $205,000 for Uleau). These are classic equity grants and compensation plan amendments under Item 5.02(e).
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-14
Item 5.02
The disclosure centers on a revised letter agreement with CEO Stephen Willard that amends his compensatory arrangements, including removal of base salary deferral, establishment of an annual cash bonus program (45% target), modification of severance and change-of-control benefits, and acceleration of equity vesting from four years to three years. This is a material modification of executive compensation terms, not a departure or appointment.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-14
Item 5.02
The filing discloses board approval on July 10, 2026 of restricted stock unit (RSU) awards to directors and officers, including CEO Vuong Trieu (2,000 RSUs), Chief Medical Officer Anthony Maida (1,500 RSUs), and other named executives. The RSUs are contingent equity compensation subject to performance and time-based vesting tied to uplisting onto a national stock exchange by June 30, 2027. This is a compensatory arrangement for named executives and directors, squarely within Item 5.02(e) disclosure requirements.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-13
Item 5.02
The disclosure centers on an amendment to the Executive Agreement of Lloyd A. Hajdik, the President and CEO, that restructures his severance benefits payable upon qualifying termination events. This is a compensatory arrangement modification affecting a named executive officer's severance terms, which falls squarely within exec_compensation rather than exec_departure (no departure occurred) or exec_appointment (no new role taken).
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 92%
filed 2026-07-13
The 6-K discloses one-time special discretionary bonus awards to two directors (Mr. Lee Seng Chi, chairman and CEO, and Mr. Thien Chiet Chai, director) satisfied by issuance of Class B shares totaling 50,000 shares valued at US$100,000. This is a compensatory arrangement for named executives and constitutes a material disclosure of equity compensation that would affect a reasonable investor's assessment of executive remuneration and potential dilution.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 95%
filed 2026-07-13
EX-99.1
This exhibit is Polyrizon's Compensation Policy for Executive Officers and Directors, adopted on July 13, 2026, pursuant to Israeli Companies Law requirements. It comprehensively sets forth compensation instruments (base salary, benefits, cash bonuses, equity awards, change-of-control provisions, and termination terms), performance objectives, bonus formulas, equity vesting requirements, and clawback provisions. The policy governs compensation arrangements approved after its adoption date and applies for three years unless amended. This is a material disclosure of compensatory arrangements for executive officers and directors that would affect a reasonable investor's assessment of the company's governance and executive incentive structure.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 85%
filed 2026-07-13
EX-99.1
This announcement updates the grant of RSUs (Restricted Stock Units) under the 2021 and 2022 RSU Schemes and options under the Post IPO Share Option Scheme. The disclosure concerns equity compensation awards to executives and employees, which falls squarely within executive compensation. The material correction of the AGM date (May 19, 2025 vs. May 20, 2026) clarifies the authorization basis for these equity grants, making this a material disclosure affecting investor understanding of executive incentive arrangements.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-07-13
Item 1.01
Compass Diversified Holdings entered into a Ninth Amended and Restated Management Services Agreement that materially restructures the external manager's compensation, reducing the base management fee from 2.00% to a tiered structure of 1.25%-1.0% of Adjusted Net Assets and replacing the incentive fee with Share Alignment and Performance-Based Awards tied to TSR and EBITDA metrics. The amendment is expected to reduce total 2027 management fees by approximately $19–22 million while introducing ownership guidelines and clawback protections to strengthen shareholder alignment.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 85%
filed 2026-07-13
The filing discloses a new employment agreement with Tyler Luck (CEO) executed on June 28, 2026, detailing comprehensive compensatory arrangements including base salary of $360,000, one-time payments totaling $275,000, a non-qualified stock option grant of 100,000 shares with a four-year vesting schedule, and performance-based compensation tied to Russell 1000 inclusion, patent licensing revenue, and market capitalization milestones. While the agreement also establishes employment terms and duration, the substantive disclosure centers on the compensation structure and equity grants, making this primarily an exec_compensation event under Item 5.02(e).
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-07-13
Item 5.02
Shareholders approved a 2026 Amendment to the Company's 2023 Omnibus Incentive Compensation Plan at the Annual Meeting, which establishes the framework for granting equity awards (options, restricted stock, RSUs, PSUs, and other stock-based awards) to employees, officers, consultants, and non-employee directors.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-13
Item 5.02
The disclosure centers on the Compensation Committee's approval on July 11, 2026 of the 2026 Long Term Incentive Program and 2026 Short Term Incentive Program for named executive officers. The filing details equity awards (RSUs and PSUs with specific vesting and performance metrics) and cash bonus opportunities for Mark Phelan, Scott Levin, and Brett Summerer. This is a classic compensatory arrangement disclosure under Item 5.02(e), material to investors assessing executive incentive structures and retention.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-07-10
Item 5.02
The disclosure centers on an amendment to William Greenman's employment agreement establishing compensatory terms for his new role as Executive Chairman, including a $500,000 annual base salary, 80% target cash bonus for 2026, and COBRA premium reimbursement. While the role transition itself occurred on July 1, 2026, the material disclosure here is the contractual compensation arrangement amendment executed July 6, 2026, which is the substance of the Item 5.02(e) filing.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 92%
filed 2026-07-10
EX-99.1
This exhibit is the Third Amended and Restated Equity Incentive Plan for Lithium Argentina AG, which establishes the framework for granting equity awards (Options, Deferred Share Units, and Restricted Share Rights) to employees and directors. The plan document itself constitutes a disclosure of compensatory arrangements for named executives and directors, falling squarely within the exec_compensation category. The materiality is high because equity incentive plans are fundamental governance and compensation instruments that affect executive retention, incentive alignment, and shareholder dilution.
View raw filing on EDGAR →